Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Poseida Therapeutics management to meet with Piper Sandler » 04:55
04/24/24
04/24
04:55
04/24/24
04:55
PSTX

Poseida Therapeutics

$2.16 /

+ (+0.00%)

Meeting to be held in New…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a week ago
Conference/Events
Poseida Therapeutics management to meet with Piper Sandler » 15:05
04/16/24
04/16
15:05
04/16/24
15:05
PSTX

Poseida Therapeutics

$2.06 /

-0.36 (-14.88%)

Meeting to be held in New…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Poseida Therapeutics files to sell 8.33M shares of common stock for holders 17:04
04/08/24
04/08
17:04
04/08/24
17:04
PSTX

Poseida Therapeutics

$2.97 /

-0.015 (-0.50%)

 
Hot Stocks
Poseida: Phase 1 data supports potential of P-BCMA-ALLO1 therapy in MM » 12:06
04/08/24
04/08
12:06
04/08/24
12:06
PSTX

Poseida Therapeutics

$2.99 /

+0.005 (+0.17%)

Poseida Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
Hot Stocks
Poseida Therapeutics names Syed Rizvi, M.D., as Chief Medical Officer » 16:06
03/25/24
03/25
16:06
03/25/24
16:06
PSTX

Poseida Therapeutics

$3.09 /

-0.015 (-0.48%)

Poseida Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Poseida Therapeutics granted FDA orphan designation for P-BCMA-ALLO1 » 16:07
03/13/24
03/13
16:07
03/13/24
16:07
PSTX

Poseida Therapeutics

$3.34 /

+0.175 (+5.53%)

, RHHBY

Roche

$35.15 /

+ (+0.00%)

Poseida Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Poseida Therapeutics' treatment of multiple myeloma gets FDA orphan designation » 18:58
03/12/24
03/12
18:58
03/12/24
18:58
PSTX

Poseida Therapeutics

$3.17 /

-0.255 (-7.46%)

According to a post on…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Poseida Therapeutics reports Q4 EPS (27c), consensus (39c) » 16:12
03/07/24
03/07
16:12
03/07/24
16:12
PSTX

Poseida Therapeutics

$3.41 /

-0.18 (-5.01%)

Reports Q4 revenue $25M,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a quarter ago
Recommendations
Poseida Therapeutics price target raised to $10 from $8 at Piper Sandler » 08:36
12/11/23
12/11
08:36
12/11/23
08:36
PSTX

Poseida Therapeutics

$3.16 /

+0.1 (+3.27%)

, RHHBY

Roche

$36.00 /

+0.42 (+1.18%)

Piper Sandler raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Poseida Therapeutics price target raised by $5 at H.C. Wainwright, here's why » 06:21
12/11/23
12/11
06:21
12/11/23
06:21
PSTX

Poseida Therapeutics

$3.16 /

+0.1 (+3.27%)

H.C. Wainwright raised…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Poseida presents efficacy, safety results from Phase 1 study of P-BCMA-ALLO1 » 16:53
12/10/23
12/10
16:53
12/10/23
16:53
PSTX

Poseida Therapeutics

$3.16 /

+0.1 (+3.27%)

, RHHBY

Roche

$36.00 /

+0.42 (+1.18%)

Poseida Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Poseida Therapeutics reports Q3 EPS (35c), consensus (29c) » 16:25
11/09/23
11/09
16:25
11/09/23
16:25
PSTX

Poseida Therapeutics

$2.20 /

-0.08 (-3.52%)

Reports Q3 revenue $9.4M,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Poseida Therapeutics names Kristin Yarema, Ph.D as CEO, effective Jan 1, 2024 » 16:32
10/09/23
10/09
16:32
10/09/23
16:32
PSTX

Poseida Therapeutics

$2.26 /

-0.085 (-3.63%)

, ATRA

Atara Biotherapeutics

$1.52 /

+0.1 (+7.07%)

Poseida Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Poseida Therapeutics price target lowered to $14 from $17 at Cantor Fitzgerald » 07:28
08/09/23
08/09
07:28
08/09/23
07:28
PSTX

Poseida Therapeutics

$1.98 /

+ (+0.00%)

Cantor Fitzgerald lowered…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Poseida Therapeutics reports Q2 EPS (32c), consensus (53c) » 16:29
08/08/23
08/08
16:29
08/08/23
16:29
PSTX

Poseida Therapeutics

$1.98 /

+ (+0.00%)

Reports Q2 revenue $20M,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Poseida Therapeutics trading resumes 09:50
08/07/23
08/07
09:50
08/07/23
09:50
PSTX

Poseida Therapeutics

$1.62 /

+ (+0.00%)

 
Hot Stocks
Poseida announces strategic investment by Astellas Pharma » 09:07
08/07/23
08/07
09:07
08/07/23
09:07
PSTX

Poseida Therapeutics

$1.62 /

+ (+0.00%)

, ALPMY

Astellas Pharma

$13.92 /

-0.06 (-0.43%)

Poseida Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Poseida Therapeutics trading halted, news pending 08:55
08/07/23
08/07
08:55
08/07/23
08:55
PSTX

Poseida Therapeutics

$1.62 /

+ (+0.00%)

 
Hot Stocks
Poseida granted orphan status for transcarbamylase deficiency treatment » 12:28
07/31/23
07/31
12:28
07/31/23
12:28
PSTX

Poseida Therapeutics

$1.74 /

+0.02 (+1.16%)

The FDA granted Poseida…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Poseida Therapeutics announces FDA clearance of IND for P-CD19CD20-ALLO1 » 08:09
07/05/23
07/05
08:09
07/05/23
08:09
PSTX

Poseida Therapeutics

$1.74 /

-0.025 (-1.42%)

, RHHBY

Roche

$38.18 /

-0.02 (-0.05%)

Poseida Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Poseida Therapeutics to join Russell 3000, Russell 2000 Indexes » 08:05
06/26/23
06/26
08:05
06/26/23
08:05
PSTX

Poseida Therapeutics

$2.36 /

-0.15 (-5.99%)

Poseida Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Poseida Therapeutics presents preclinical data for its gene therapy programs » 08:07
05/18/23
05/18
08:07
05/18/23
08:07
PSTX

Poseida Therapeutics

$2.69 /

-0.205 (-7.09%)

Poseida Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Poseida Therapeutics reports Q1 EPS (45c), consensus (45c) » 16:31
05/09/23
05/09
16:31
05/09/23
16:31
PSTX

Poseida Therapeutics

$3.41 /

+0.03 (+0.89%)

Reports Q1 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.